About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 154073, 5 pages
http://dx.doi.org/10.1155/2013/154073
Research Article

Feasibility of a Microarray-Based Point-of-Care CYP2C19 Genotyping Test for Predicting Clopidogrel On-Treatment Platelet Reactivity

1Department of Laboratory Medicine, Bucheon St. Mary's Hospital, 2 Sosa-dong, Wonmi-gu, Gyeonggi-do, Bucheon-si 420-717, Republic of Korea
2Catholic Laboratory Development and Evaluation Center, College of Medicine, The Catholic University of Korea, Seoul 137-701, Republic of Korea
3Cardiovascular Center and Cardiology Division, Uijeongbu St. Mary’s Hospital, Uijeongbu 480-717, Republic of Korea
4Cardiovascular Center and Cardiology Division, Seoul St. Mary’s Hospital, 505 Banpo-dong, Seocho-gu, Seoul 137-701, Republic of Korea

Received 17 August 2012; Accepted 11 March 2013

Academic Editor: Yasemin Alanay

Copyright © 2013 Hyojin Chae et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hyojin Chae, Myungshin Kim, Yoon-Seok Koh, et al., “Feasibility of a Microarray-Based Point-of-Care CYP2C19 Genotyping Test for Predicting Clopidogrel On-Treatment Platelet Reactivity,” BioMed Research International, vol. 2013, Article ID 154073, 5 pages, 2013. doi:10.1155/2013/154073